Minimum costs to manufacture new treatments for COVID-19

INTRODUCTION: ‘Repurposing’ existing drugs to treat COVID-19 is vital to reducing mortality and controlling the pandemic. Several promising drugs have been identified and are in various stages of clinical trials globally. If efficacy of these drugs is demonstrated, rapid, mass availability at an aff...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Virus Erad
Hlavní autoři: Hill, Andrew, Wang, Junzheng, Levi, Jacob, Heath, Katie, Fortunak, Joseph
Médium: Artigo
Jazyk:Inglês
Vydáno: Mediscript Ltd 2020
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7331548/
https://ncbi.nlm.nih.gov/pubmed/32405423
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky